News und Analysen
Alte Goldlegenden, die wieder aufleben
Klimafreundliche Fahrzeuge brauchen Rohstoffe
ImmunoPrecise to Report Financial Results and Business Highlights for Fiscal Year 2021
IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (NASDAQ:IPA) (TSX VENTURE:IPA) a leader in full-service, therapeutic antibody discovery and development, today announced the Company will host
Wann bricht der Goldpreis aus?
Nickelpreis – vielleicht kurz vor dem Sprung
Ob Gold eine Sommerpause einlegt
Eurofins Discovery and ImmunoPrecise Announce Collaboration to Expand their Antibody Discovery Platform
IMMUNOPRECISE ANTIBODIES LTD (the "Company" or "IPA") (NASDAQ: IPA) (TSX VENTURE: IPA) the market leader in full-service therapeutic discovery and development and Eurofins Discovery, the leading
Histopathology Preclinical Data from ImmunoPrecise’s Polytope™ Program Confirms Lung Inflammation Reduction
IMMUNOPRECISE ANTIBODIES LTD (the "Company" or "IPA") (NASDAQ: IPA) (TSX VENTURE: IPA) today announced additional results from its in vivo hamster challenge efficacy study of TATX-03a PolyTope™
Tokens.com Adds Figment as New Staking Integration Partner
Tokens.com Corp. (NEO: COIN) (FSE: 76M) (“Tokens.com” or the “Company”), a publicly-traded Blockchain technology company that provides transaction processing and validation services for various
Preclinical Data from ImmunoPrecise’s Drug Pipeline to be Presented During the BIO International Partnering Event
IMMUNOPRECISE ANTIBODIES LTD (the "Company" or "IPA") (NASDAQ: IPA) (TSX VENTURE: IPA) today announced the results from in vitro characterizations investigating TATX-21, a novel potential
Tokens.com Publishes a Letter to Shareholders Regarding its Staking Operations Powering the Next Generation of Finance
Tokens.com Corp. (NEO: COIN) (FSE: 76M) (“Tokens.com” or the “Company”), a Blockchain technology company that provides transaction processing and validation services for various digital assets that
ImmunoPrecise Announces Appointment of Dr. Ilse Roodink to the Role of Chief Scientific Officer and Resignation of Dr. Yasmina Abdiche
IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (NASDAQ: IPA) (TSX VENTURE: IPA) a leader in full-service, therapeutic antibody discovery and development, announced today that Dr. Yasmina
Tokens.com Publishes a Letter to Shareholders Regarding its Near Zero-Energy Consumption Crypto Business
Tokens.com Corp. (NEO: COIN) (FSE: 76M) (“Tokens.com” or the “Company”) publishes a letter to shareholders regarding the Company’s business model, particularly as it relates to energy consumption.
METABOLIC EXPLORER : METEX provides an update on the situation at its Amiens plant.
METEX provides an update on the situation at its Amiens plant
Clermont-Ferrand, May 26, 2021 – (FR0004177046 METEX), METabolic EXplorer (METEX), specialized in the design, development and
Lomiko Metals CEO Speaks on the Electric Vehicle Revolution at the Emerging Growth Conference on May 26, 2021
Lomiko Metals Inc. (TSX-V: LMR, OTC: LMRMF, FSE: DH8C) (Lomiko or the “Company”) invites individuals, institutional investors, advisors and analysts to attend its real-time, interactive
ImmunoPrecise Names Dr. Dion Neame to Strategic Advisory Board
IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (NASDAQ: IPA) (TSX VENTURE: IPA) a leader in full-service, therapeutic antibody discovery and development, today announced that Dr. Dion Neame
Tokens.com Purchases Additional Operating Assets
Tokens.com Corp. (NEO:COIN) (FSE:76M) (“Tokens.com” or “the Company”) is a blockchain technology company that provides transaction processing and validation services for various digital assets that
ImmunoPrecise Moves SARS-CoV-2 PolyTope™ Cocktail Program’s Path Toward IND Filing
ImmunoPrecise Antibodies Ltd. (the "Company" or "IPA") (NASDAQ: IPA) (TSX venture: IPA) announces the completion of an efficacy-driven, preclinical study demonstrating further evidence of the in
Notice of Investment in Manufacturing Equipment at US Subsidiary UACJ Automotive Whitehall Industries
UACJ Corporation (HQ: Chiyoda-ku, Tokyo; President and Representative Director: Miyuki Ishihara) announced today its decision to invest in new manufacturing equipment for two factories operated by
Lomiko to Explore for Lithium on Bourier Project Optioned From Critical Elements
Lomiko Metals Inc. (TSX-V: LMR, OTC: LMRMF, FSE: DH8C) (Lomiko or the “Company”) and Critical Elements Lithium Corporation (TSX-V: CRE) (US OTCQX: CRECF) (FSE: F12) ("Critical Elements" or the "Com
A Paul Gill, Lomiko CEO Speaks at Edward Snowden ‘On the Record’ Event at the Private Investment Club Conference
Lomiko Metals Inc. (TSX-V: LMR, OTC: LMRMF, FSE: DH8C) (Lomiko or the “Company”) announces CEO A. Paul Gill will speak at the Edward Snowden - On the Record Virtual Conference hosted by the Private
METABOLIC EXPLORER : METEX : Signature of the Share Purchase Agreement (SPA) for the transfer of 100% of the capital of Ajinomoto Animal Nutrition Europe (AANE).
Signature of the Share Purchase Agreement (SPA) for the transfer of 100% of the capital of Ajinomoto Animal Nutrition Europe (AANE)
- Favourable opinion from the employee representative bodies
- No
ImmunoPrecise Launches TATX-112 Candidate Antibody Program, for the Treatment of Cancer and Alzheimer’s Disease
IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (NASDAQ: IPA) (TSX VENTURE: IPA) a leader in full-service, therapeutic antibody discovery and development, today announced that its subsidiary
Lomiko La Loutre Metallurgical Testing Produces Concentrate Grading 97.8% Carbon and 93.5% Graphite Recovery
Lomiko Metals Inc. (TSX-V: LMR, OTC: LMRMF, FSE: DH8C) (Lomiko or the “Company”) is pleased to provide an update on its La Loutre graphite project (“La Loutre”), located in Quebec, Canada. La